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The authors conclude that the low cost and 
improvement in QOL support the continued use of 
PTA in claudication. As only 26-40% of claudicants 
have lesions amenable to angioplasty, 3'4 the overall 
benefit on QOL in the patient group as a whole is 
decreased. In contrast, supervised exercise training 
programmes are applicable to all claudicants and are 
known to increase walking distance. 5 The beneficial 
effect of supervised exercise on QOL has not been 
reported. Some degree of exercise supervision is 
essential to provide encouragement and ensure com- 
pliance as unsupervised exercise has been reported to 
effect a minimal improvement in quality of life. 6 
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Quality of Life Following Percutaneous 
Transluminal Angioplasty for Claudication 
Sir, 
The recent paper by Cook et al) showed that patients 
undergoing percutaneous transluminal angioplasty 
(PTA) have lower baseline quality of life (QOL) scores 
compared to a normal population and that revascular- 
isation improved QOL and walking distance score. We 
would like to make several points regarding this 
study. The authors have presumably used published 
figures for baseline EuroQOL scores in a normal 
population rather than comparing the 29 patients to an 
age and sex-matched control group, which would be 
more relevant Lower baseline QOL in claudicants 
compared to controls has recently been reported using 
the Nottingham Health Profile questionnaire. 2 
The EuroQOL questionnaire was completed on the 
ward prior to PTA and it is likely that the stress of 
admission to hospital would adversely affect the 
response to QOL parameters. It is possible that 
patients may also underestimate their subjective walk- 
ing distance score in order to ensure that the proce- 
dure is not cancelled due to spontaneous improve- 
ment in symptoms. Perhaps an objective treadmill 
assessment before and after PTA would more accu- 
rately reflect he correlation between improved walk- 
ing distance and QOL? The authors have failed to 
include the two patients with failed PTA in their 
analysis, although we accept hat surgery itself may 
improve QOL. A long-term assessment of the effect of 
PTA on QOL is needed as restenosis after the 6 week 
follow-up may significantly reduce the improvement 
compared to baseline levels, and may possibly lead to 
a deterioration. 
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Cranial Nerve Injuries and Carotid 
Endarterectomy 
Sir, 
Cranial nerve injuries following operations on the 
carotid bifurcation is an easily identifiable problem for 
patients but not for surgeons, at least not for all of 
them. In most reported series of carotid surgery, 
cranial nerve injuries (CNI) are infrequently men- 
tioned, and some authors have expressed the opinion 
that such injuries, should be reported only if they are 
permanent. 
In the November issue of the Journal, ~ D. Bergqvist 
and his co-workers reported the results of a very 
thorough prospective study, using the resources of the 
department of speech therapy on 689 carotid endarter- 
ectomies. As was expected, the incidence of cranial 
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